510(k) Report

510(k) · Cleared

Cleared

Cadence Total Ankle System

K201507510(k) SpecialCleared Jun 29, 202024-day reviewClass II21 CFR 888.3110

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Integra LifeSciences Corporation · HSN Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer

Cleared on Jun 29, 2020 as substantially equivalent to K151459 (Ascension Orthopedics, 2015) after a 24-day review. Its family tree reaches back 5 generations to 1992.

Decided
Jun 29, 2020
Review
24 days
Class
Class II
Product code
HSN
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K920802 (1992). No later device cites it as a predicate yet.

  1. Root · 5 generations backK920802 Alvine Total AnkleDepuy, Inc. · 1992
  2. 4 generations backK020541 Agility Ankle Revision ProsthesisDepuy, Inc. · 2002
  3. 3 generations backK051023 Topez Total Ankle ReplacementTopez Orthopedics, Inc. · 2005 · Recalled
  4. 2 generations backK100886 Inbone II Total Ankle ReplacementWrightmedicaltechnologyinc · 2010 · Recalled
  5. 1 generation backK151459 Integra Total Ankle Replacement SystemAscension Orthopedics · 2015 · Recalled
  6. This deviceK201507 Cadence Total Ankle SystemIntegra LifeSciences Corporation · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K920802Alvine Total AnkleDepuy, Inc.1992—
−4K020541Agility Ankle Revision ProsthesisDepuy, Inc.2002—
−3K051023Topez Total Ankle ReplacementTopez Orthopedics, Inc.20054
−2K100886Inbone II Total Ankle ReplacementWrightmedicaltechnologyinc20102
−1K151459Integra Total Ankle Replacement SystemAscension Orthopedics20152
0 (this device)K201507Cadence Total Ankle SystemIntegra LifeSciences Corporation2020—
FIG. 1 — Lineage of K201507, 1992–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HSN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HSN device

  1. #1 K192994 Paragon 28 APEX 3D Total Ankle Replacement…score 16.7 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K151459Integra Total Ankle Replacement System
Summary page 4
…ation No. 21 CFR 888.3110 Regulation Name Ankle joint metal/polymer semi-constrained cemented prosthesis Product Code HSN K151459 Predicate Device Integra Total Ankle Replacement System…
Ascension Orthopedics20152
†K182878Integra Salto Total Ankle SystemAscension Orthopedics20188

Also cleared against K151459: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 5 companies; a new generation was cleared every 4.8 years on median.
  • 3 of the 5 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K151459.

How does its category compare?

All HSN devices

HSN Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · HSN

3in 2025

2009: 12010: 22011: 12012: 22013: 42014: 22015: 32016: 32017: 42018: 42019: 22020: 62021: 42022: 12023: 62024: 72025: 32026 (partial year): 2
2007high 7 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HSN

58in 2025

2013: 89 days median2015: 233 days median2016: 216 days median2017: 148 days median2018: 89 days median2020: 234 days median2021: 109 days median2023: 112 days median2024: 115 days median2025: 58 days median
2007high 234 (2020) · low 58 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HSN

1in 2023

2013: 32016: 12017: 22019: 12021: 32022: 22023: 1
2007high 3 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HSN

1,645in 2025

2007: 502008: 662009: 662010: 1202011: 1392012: 1002013: 1062014: 652015: 732016: 1112017: 962018: 1872019: 2772020: 2812021: 2372022: 4532023: 7962024: 1,0952025: 1,645
2007high 1,645 (2025) · low 50 (2007)2025

MAUDE reports naming product code HSN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—050
20080—066
20091—066
20102—0120
20111—0139
20122—0100
20134893106
20142—065
20153233073
201632161111
20174148296
20184890187
20192—1277
202062340281
202141093237
20221—2453
202361121796
2024711501,095
202535801,645
20262—0—

What is it indicated for?

The Cadence Total Ankle System is designed to treat ankle arthritis through replacement of the ankle joint with a prosthesis, thereby reducing pain, restoring alignment, and allowing for movement at the replaced joint. The Cadence Total Ankle System is indicated for use to treat: - Systemic arthritis of the ankle (e.g. rheumatoid arthritis, hemochromatosis) - Primary arthritis (e.g. degenerative disease) - Secondary arthritis (e.g. post-traumatic…

Read the full statement (130 words)

The Cadence Total Ankle System is designed to treat ankle arthritis through

replacement of the ankle joint with a prosthesis, thereby reducing pain, restoring

alignment, and allowing for movement at the replaced joint.

The Cadence Total Ankle System is indicated for use to treat:

- Systemic arthritis of the ankle (e.g. rheumatoid arthritis, hemochromatosis)

- Primary arthritis (e.g. degenerative disease)

- Secondary arthritis (e.g. post-traumatic, avascular necrosis, if minimally 2/3

of the talus is preserved)

Cadence Total Ankle System is also indicated for revision surgeries following

failed total ankle replacement and non-union/mal-union of ankle arthrodesis.

Provided sufficient bone stock is present.

Note – In the United States, this device is intended for cemented use only.

Note – Outside the United States, this device is intended for cemented or cementless use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K201507: Cadence Total Ankle System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K201507

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026